Search results
T2 Biosystems, Inc. (NASDAQ:TTOO) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoT2 Biosystems, Inc. (NASDAQ:TTOO) Q1 2024 Earnings Call Transcript May 6, 2024 T2 Biosystems, Inc....
Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results
WFRV 5 Green Bay· 6 hours agoAccelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial preliminary results for the first quarter ended March 31, 2024. In parallel to the clinical trial work, we are developing our Gram Positive PBC menu.
Earnings call: T2 Biosystems reports growth and strategic focus in Q1 2024
Investing.com· 2 days agoT2 Biosystems (NASDAQ: TTOO ), a leader in the rapid detection of sepsis and other health threats,...
Karius raises $100M to expand access to multi-pathogen blood test
MedTech Dive via Yahoo Finance· 3 days agoKarius plans to use the funding to expand the test outside of the hospital setting and support...
When good bacteria go bad: New links between bacteremia and probiotic use
Medical Xpress· 6 days agoProbiotics offer a range of health benefits, but their adverse effects can occasionally lead to bacteremia, wherein bacteria circulate in the bloodstream throughout the body. In Japan, Clostridium ...
Study highlights overuse of antibiotics in newborns with suspected sepsis
Medical Xpress· 2 days agoThe study is published in the journal JAMA Network Open and is based on data on newborns in Sweden from 2012 to 2020. The study covers more than 1 million newborns with a gestational age greater ...
Becton Dickinson Raises FY24 EPS Guidance After 5 Percent Fiscal Q2 Revenue Increase
GenomeWeb News· 7 days agoThe company reported high-single-digit revenue growth in microbiology platforms, including those for blood culture, tuberculosis, and ID/AST.
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoAllschwil, Switzerland, May 03, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that
Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.
FOX 59 Indianapolis· 7 days agoAccelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Wednesday, May 8, 2024, at 4:30 p.m. Eastern Time to review 2024 first quarter results ...